Drug Information

Drug General Information
Drug ID
D0K8MN
Former ID
DNC008484
Drug Name
5-Biphenyl-4-ylmethyl-2-isobutyl-2H-tetrazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529434]
Formula
C18H20N4
Canonical SMILES
CC(C)CN1N=C(N=N1)CC2=CC=C(C=C2)C3=CC=CC=C3
InChI
1S/C18H20N4/c1-14(2)13-22-20-18(19-21-22)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14H,12-13H2,1-2H3
InChIKey
PPXBPBABGOMYLY-UHFFFAOYSA-N
PubChem Compound ID
44448617
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [529434]
Cannabinoid receptor 2 Target Info Inhibitor [529434]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signalinghsa04080:Neuroactive ligand-receptor interaction
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like
References
Ref 529434Bioorg Med Chem Lett. 2008 May 1;18(9):2820-4. Epub 2008 Apr 4.New tetrazole-based selective anandamide uptake inhibitors.
Ref 529434Bioorg Med Chem Lett. 2008 May 1;18(9):2820-4. Epub 2008 Apr 4.New tetrazole-based selective anandamide uptake inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.